10 results on '"Haslbauer F"'
Search Results
2. Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial
3. 195P REACH AUT: Efficacy and safety of first-line (1L) ribociclib (RIB) + endocrine therapy (ET) in HR+, HER2- metastatic breast cancer (MBC) from a real-world (RW) study: 3rd interim analysis
4. 172P REACHAUT: Real-world study of first-line (1L) ribociclib (RIB) + endocrine therapy (ET) in HR+, HER2- metastatic breast cancer (MBC)
5. 1787P - Prospective observational study to evaluate the persistence of treatment with denosumab (dmab) in patients (pts) with bone metastases (BM) from solid tumors (ST) in routine clinical practice: Final analysis
6. 347 (PB-142) - Real-World multicenter Austrian analysis of the safety and effectiveness of nab-paclitaxel in young and elderly patients with metastatic breast cancer
7. 241P - Safety and effectiveness of nab-paclitaxel in young and elderly patients with metastatic breast cancer: a prospective, multicenter non-interventional study
8. 1511P - Sompas: a Prospective, Non-Interventional Study (Nis) of the Management of Symptomatic Chemotherapy (Ct)-Induced Anemia (Cia) in Patients (Pts) with Colorectal (Crc), Breast (Bc) or Lung Cancer (Lc) in Austria (At) and Switzerland (Ch)
9. 0138 ABCSG-16/SALSA: Prospective, open, randomised, multicentre phase III study to assess extended adjuvant treatment with 2 or 5 years' anastrozole in postmenopausal women with endocrine-responsive early breast cancer after 5 years of initial adjuvant endocrine therapy
10. Continued trastuzumab therapy for patients with HER2-positive breast cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.